Department of Cellular Signalling, Mossakowski Medical Research Centre, Polish Academy of Sciences, 5 Pawińskiego Street, Warsaw, Poland.
Laboratory of Preclinical Research and Environmental Agents, Department of Neurosurgery, Mossakowski Medical Research Centre, Polish Academy of Sciences, 5 Pawińskiego Street, 02-106, Warsaw, Poland.
Mol Neurobiol. 2018 Jan;55(1):727-740. doi: 10.1007/s12035-016-0317-1. Epub 2017 Jan 3.
Alpha-synuclein (ASN) is a presynaptic protein that can easily change its conformation under different types of stress. It's assumed that ASN plays an important role in the pathogenesis of Parkinson's and Alzheimer's disease. However, the molecular mechanism of ASN toxicity has not been elucidated. This study focused on the role of extracellular ASN (eASN) in regulation of transcription of sirtuins (Sirts) and DNA-bound poly(ADP-ribose) polymerases (PARPs) - proteins crucial for cells' survival/death. Our results indicate that eASN enhanced the free radicals level, decreased mitochondria membrane potential, cells viability and activated cells' death. Concomitantly eASN activated expression of antioxidative proteins (Sod2, Gpx4, Gadd45b) and DNA-bound Parp2 and Parp3. Moreover, eASN upregulated expression of Sirt3 and Sirt5, but downregulated of Sirt1, which plays an important role in cell metabolism including Aβ precursor protein (APP) processing. eASN downregulated gene expression of APP alpha secretase (Adam10) and metalloproteinases Mmp2, Mmp10 but upregulated Mmp11. Additionally, expression and activity of pro-survival sphingosine kinase 1 (Sphk1), Akt kinase and anti-apoptotic protein Bcl2 were inhibited. Moreover, higher expression of pro-apoptotic protein Bax and enhancement of apoptotic cells' death were observed. Summarizing, eASN significantly modulates transcription of Sirts and enzymes involved in APP/Aβ metabolism and through these mechanisms eASN toxicity may be enhanced. The inhibition of Sphk1 and Akt by eASN may lead to disturbances of survival pathways. These results suggest that eASN through alteration of transcription and by inhibition of pro-survival kinases may play important pathogenic role in neurodegenerative disorders.
α-突触核蛋白(ASN)是一种突触前蛋白,在不同类型的应激下容易改变其构象。据推测,ASN 在帕金森病和阿尔茨海默病的发病机制中发挥重要作用。然而,ASN 毒性的分子机制尚未阐明。本研究重点研究细胞外 ASN(eASN)在调节沉默调节蛋白(Sirts)和 DNA 结合多聚(ADP-核糖)聚合酶(PARPs)转录中的作用-这些蛋白对细胞的存活/死亡至关重要。我们的研究结果表明,eASN 增强了自由基水平,降低了线粒体膜电位,细胞活力并激活了细胞死亡。同时,eASN 激活了抗氧化蛋白(Sod2、Gpx4、Gadd45b)和 DNA 结合的 Parp2 和 Parp3 的表达。此外,eASN 上调了 Sirt3 和 Sirt5 的表达,但下调了在细胞代谢中起重要作用的 Sirt1,包括 Aβ 前体蛋白(APP)加工。eASN 下调了 APP α 分泌酶(Adam10)和金属蛋白酶 Mmp2、Mmp10 的基因表达,但上调了 Mmp11。此外,抑制了促生存鞘氨醇激酶 1(Sphk1)、Akt 激酶和抗凋亡蛋白 Bcl2 的表达和活性。此外,观察到促凋亡蛋白 Bax 的表达增加和凋亡细胞死亡的增强。综上所述,eASN 显著调节 Sirts 和参与 APP/Aβ 代谢的酶的转录,通过这些机制,eASN 毒性可能增强。eASN 对 Sphk1 和 Akt 的抑制可能导致生存途径的紊乱。这些结果表明,eASN 通过改变转录并抑制促生存激酶,可能在神经退行性疾病中发挥重要的致病作用。